TCL Archive Also NIH unveils Roadmap initiatives, releases four RFAs; Director Zerhouni defends peer review before House, Senate oversight committees, seeks greater authority for trans-NIH initiatives. October 3, 2003
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006